Teschler H, Stamatis G, Farhat A A, Meyer F J, Steveling H, Weisskopf V, Greschuchna D, Costabel U, Konietzko N
Abteilung Pneumologie, Universitätsklinik, Ruhrlandklinik Essen der LVA Rheinprovinz.
Dtsch Med Wochenschr. 1996 Oct 11;121(41):1248-54. doi: 10.1055/s-2008-1043135.
Lung volume reduction (LVR) is a new surgical approach designed to relieve shortness of breath and improve exercise tolerance in patients with severe lung emphysema. The aim of this study was to analyse changes of lung function, gas exchange, exercise tolerance and degree of dyspnoea one and 3 months after LVR.
Seventeen patients (15 men and two women; mean age 53 [38-68] years) with severe emphysema (six with alpha 1-PI deficiency) underwent unilateral (n = 14) or bilateral (n = 3) LVR surgery. One week before and one and 3 months after surgery pulmonary function tests, arterial blood gas analysis at rest breathing room air, 6-minute walking distance and dyspnoea score (Medical Research Council Scale) were determined.
There was a significant increase in forced expiratory vital capacity after one second (FEV1, P < 0.001), and a significant decrease in total lung capacity (TLC, P < 0.0001) and residual volume (RV, P < 0.0001). The mean increase in FEV1 was 39% and in PaO2 9%. The mean decrease in TLC was 20%, in RV 26% (P < 0.001; both comparisons), and in paCO2 4% (not significant). The mean 6-minute walking distance increased by 96% from 229 to 405 meters (P < 0.0001). The mean dyspnoea score on a five point scale (0-4 points) decreased by 52% from 3.4 to 1.6. With the exception of the improved inspiratory vital capacity the postoperative results at one and 3 months after LVR did not differ significantly. All patients were alive 3 months postoperatively.
In patients with severe emphysema surgical LVR shows significantly improved pulmonary function, gas exchange, dyspnoea and walking distance as assessed one and three months postoperatively. The early mortality seems to be low.
肺减容术(LVR)是一种旨在缓解重度肺气肿患者气短症状并提高运动耐力的新型手术方法。本研究的目的是分析肺减容术后1个月和3个月时肺功能、气体交换、运动耐力及呼吸困难程度的变化。
17例重度肺气肿患者(15例男性,2例女性;平均年龄53 [38 - 68]岁,其中6例伴有α1-抗胰蛋白酶缺乏)接受了单侧(n = 14)或双侧(n = 3)肺减容手术。在手术前1周以及术后1个月和3个月时,测定肺功能、静息呼吸室内空气时的动脉血气分析、6分钟步行距离以及呼吸困难评分(医学研究委员会量表)。
一秒用力呼气容积(FEV1)显著增加(P < 0.001),肺总量(TLC,P < 0.0001)和残气量(RV,P < 0.0001)显著减少。FEV1的平均增幅为39%,动脉血氧分压(PaO2)的平均增幅为9%。TLC的平均降幅为20%,RV的平均降幅为26%(P < 0.001;两项比较均如此),动脉血二氧化碳分压(PaCO2)的平均降幅为4%(无显著差异)。6分钟步行距离的平均值从229米增加到405米,增幅为96%(P < 0.0001)。五点量表(0 - 4分)的平均呼吸困难评分从3.4分降至1.6分,降幅为52%。除吸气肺活量有所改善外,肺减容术后1个月和3个月时的术后结果无显著差异。所有患者术后3个月均存活。
对于重度肺气肿患者,手术肺减容术后1个月和3个月时评估显示,肺功能、气体交换、呼吸困难及步行距离均有显著改善。早期死亡率似乎较低。